Atlas Trials

Therasphere for Unresectable Primary or Secondary Liver Neoplasia

Clinical trial NCT02960620 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT02960620
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Liver CancerLiver NeoplasmsHepatoCellular Carcinoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.